Cargando…

Antibodies to Human Papillomavirus 16, 18, 58, and 6b Major Capsid Proteins among Japanese Females

Among genital human papillomaviruses (HPVs), the so‐called high‐risk (HPV 16, 18, etc.) and intermediate‐risk (HPV 58, etc.) viruses are believed to be etiologically associated with cervical cancer. To estimate the extent of infection with common HPVs among Japanese females, we examined 328 sera fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Koji, Yoshikawa, Hiroyuki, Taketani, Yuji, Yoshiike, Kunito, Kanda, Tadahito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921431/ https://www.ncbi.nlm.nih.gov/pubmed/9197528 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00391.x

Ejemplares similares

Growth Dependence of Human Papillomavirus 16 DNA‐positive Cervical Cancer Cell Lines and Human Papillomavirus 16‐Transformed Human and Rat Cells on the Viral Oncoproteins
por: Watanabe, Sumie, et al.
Publicado: (1993)

Enhancer‐promoter Activity of Human Papillomavirus Type 16 Long Control Regions Isolated from Cell Lines SiHa and CaSki and Cervical Cancer Biopsies
por: Kozuka, Takuyo, et al.
Publicado: (2000)

Detection of Human Antibody against the Human Papillomavirus Type 16 E7 Protein
por: Hashido, Madoka, et al.
Publicado: (1991)

Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
por: Ishii, Yoshiyuki, et al.
Publicado: (2007)

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan
por: Tanaka, Kohsei, et al.
Publicado: (2022)

Genomic Organization of Human Papillomavirus Type 18 in Cervical Cancer Specimens
por: Kitagawa, Kyoko, et al.
Publicado: (1996)

Maturation of the Human Papillomavirus 16 Capsid
por: Cardone, Giovanni, et al.
Publicado: (2014)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

Detection of Human Papillomavirus Types 6/11, 16 and 18 in Exfoliated Cells from the Uterine Cervices of Japanese Women with and without Lesions
por: Yokota, Harushige, et al.
Publicado: (1990)

Genotype Distribution of Human Papillomaviruses in Japanese Women with Abnormal Cervical Cytology
por: Kondo, Kazunari, et al.
Publicado: (2012)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China
por: Fang, Liyuan, et al.
Publicado: (2020)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019)

Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women
por: Liu, Ying, et al.
Publicado: (2017)

Observations on the expression of human papillomavirus major capsid protein in HeLa cells
por: Xiao, Chang-Yi, et al.
Publicado: (2015)

α-Defensin HD5 Stabilizes Human Papillomavirus 16 Capsid/Core Interactions
por: Gulati, Neetu M., et al.
Publicado: (2019)

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer
por: Tenjimbayashi, Yuri, et al.
Publicado: (2017)

Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations
por: Nakagawa, S, et al.
Publicado: (1999)

Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China
por: Wang, Ying, et al.
Publicado: (2023)

Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly
por: Bishop, Brooke, et al.
Publicado: (2007)

Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33
por: Roth, Stefanie D, et al.
Publicado: (2006)

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program
por: Matsumoto, Koji, et al.
Publicado: (2019)

Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era
por: Kitamura, Tadaichi, et al.
Publicado: (2023)

Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors
por: Onuki, Mamiko, et al.
Publicado: (2018)

Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco
por: El-Aliani, Aissam, et al.
Publicado: (2017)

Human Papillomavirus Types 52 and 58 Are Prevalent in Uterine Cervical Squamous Lesions from Japanese Women
por: Takehara, Kazuhiro, et al.
Publicado: (2011)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
por: Zhang, Donghong, et al.
Publicado: (2010)

Distribution of Human Papillomavirus 52 and 58 Genotypes, and Their Expression of p16 and p53 in Cervical Neoplasia
por: Kim, Tae Eun, et al.
Publicado: (2014)

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
por: Onuki, Mamiko, et al.
Publicado: (2022)

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
por: Bissett, Sara L., et al.
Publicado: (2014)

Isoforms of the Papillomavirus Major Capsid Protein Differ in Their Ability to Block Viral Spread and Tumor Formation
por: Hasche, Daniel, et al.
Publicado: (2022)

Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions
por: Hirose, Yusuke, et al.
Publicado: (2019)

Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants
por: Chen, Zigui, et al.
Publicado: (2017)

α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome
por: Wiens, Mayim E., et al.
Publicado: (2017)

Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
por: Wan, Bing, et al.
Publicado: (2022)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bscjs53oc8r99n500tjaagng5k